PKM and cancer: Introduction of a SAICAR-insensitive or a non-phosphorylatable PKM2 mutant inhibited the EGF-stimulated ERK activation and consequent cancer cell proliferation, suggesting SAICAR-induced PKM2 protein kinase activity is required for EGF-mediated cancer cell proliferation [84].